Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials.

H H van der ZeeM LongcoreZ GengAmit Garg

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)

Flare reduction is an important measure in HS that correlates with clinically meaningful improvement in HRQOL. ADAew reduces HS flare through 12 and subsequent 36 weeks of treatment.

Keyphrases

hidradenitis suppurativa
rheumatoid arthritis
combination therapy
juvenile idiopathic arthritis
disease activity